Patents-Review.com
ClassID:

20266 ⎘

A61K31/26 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters

Recent Application in this class:
#1
20260144780
2026-05-28

COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION

 #2
20260124284
2026-05-07

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER

 #3
20260083667
2026-03-26

SULFORAPHANE SUPPLEMENT IN GUMMY FORM

 #4
20260055056
2026-02-26

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

 #5
20260034137
2026-02-05

Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity

 #6
20250367272
2025-12-04

HIRUDIN FORMULA COMPOSITION WITH ANTICOAGULANT AND HYPOLIPIDEMIC EFFECTS AND PREPARATION METHOD THEREOF

 #7
20250262267
2025-08-21

CURCUMIN COMPOSITIONS AND METHODS OF USE AS AN NK3 ANTAGONIST

 #8
20250213500
2025-07-03

PHARMACEUTICAL COMPOSITION FOR IMPROVING LIFE QUALITY OF ELDERLY PEOPLE ON BASIS OF VITAMIN K2, PREPARATION METHOD THEREFOR AND USE THEREOF

 #9
20250195462
2025-06-19

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #10
20250161258
2025-05-22

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

 #11
20250161257
2025-05-22

METHOD OF TREATING SEPSIS

 #12
20250161256
2025-05-22

METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS

 #13
20250127750
2025-04-24

ISOTHIOCYANATE FUNCTIONAL COMPOUNDS AUGMENTED WITH SECONDARY ANTINEOPLASTIC MEDICAMENTS AND ASSOCIATED METHODS FOR TREATING NEOPLASMS

 #14
20250127749
2025-04-24

METHOD FOR TREATING METASTATIC PROSTATE CANCER

 #15
20250074989
2025-03-06

METHODS AND COMPOSITIONS FOR TREATING PANCREATIC DISEASE

 #16
20250064846
2025-02-27

TREATMENT AND PREVENTION OF TRIGEMINAL NEURALGIA

 #17
20250064792
2025-02-27

MUSCLE REGENERATION

 #18
20250049746
2025-02-13

Medicinal Oil for Reducing Gastrointestinal Reaction Caused by Sulforaphane (SFA) and Sulforaphene

 #19
20250032440
2025-01-30

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS

 #20
20240423967
2024-12-26

PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS

 #21
20240408165
2024-12-12

CURCUMIN COMPOSITIONS AND METHODS OF USE AS AN NK3 ANTAGONIST

 #22
20240382497
2024-11-21

PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT

 #23
20240366552
2024-11-07

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #24
20240366551
2024-11-07

MIXTURES AND COMPOSITIONS COMPRISING SULFORAPHANE AND GLYCINE

 #25
20240366550
2024-11-07

Drug for Treating Prostatitis or Benign Prostatic Hyperplasia (BPH)

 #26
20240358803
2024-10-31

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER

 #27
20240316134
2024-09-26

BLOOD FLOW INCREASING AGENT FOR DORSOLATERAL PREFRONTAL CORTEX, DORSOLATERAL PREFRONTAL CORTEX ACTIVATOR, FOOD FOR INCREASING BLOOD FLOW IN DORSOLATERAL PREFRONTAL CORTEX, AND FOOD FOR ACTIVATING DORSOLATERAL PREFRONTAL CORTEX

 #28
20240307341
2024-09-19

Treatment of COVID-19 and Associated Pathologies

 #29
20240301427
2024-09-12

Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking Defects

 #30
20240279169
2024-08-22

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

 #31
20240262916
2024-08-08

METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE

 #32
20240216324
2024-07-04

Use of Sulforaphene in Preparation of Pharmaceutical Composition for Improving and Treating Leukotrichia and/or Alopecia

 #33
20240156846
2024-05-16

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS

 #34
20240139142
2024-05-02

METHOD FOR PREVENTING OR TREATING LIVER DISEASE

 #35
20240130999
2024-04-25

Inhibition of SLC4A4 in the Treatment of Cancer

 #36
20240122893
2024-04-18

METHODS FOR INHIBITING CORONAVIRUSES USING SULFORAPHANE

 #37
20240115543
2024-04-11

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #38
20240108596
2024-04-04

METHODS FOR IMPROVING PHYSICAL EXERCISE PERFORMANCE

 #39
20240041885
2024-02-08

CELLULAR HEALTH NUTRITIONAL PRODUCT

 #40
20240016789
2024-01-18

COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION

 #41
20230414696
2023-12-28

Curcumin compositions and methods of use as an NK3 antagonist

 #42
20230414552
2023-12-28

NOVEL METHODS

 #43
20230372277
2023-11-23

COMPOSITION FOR PROMOTING HAIR GROWTH AND/OR INHIBITING HAIR LOSS

 #44
20230364049
2023-11-16

COMBINATION OF P2Y6 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS

 #45
20230346002
2023-11-02

USE OF ISOTHIOCYANATE IN SMOKELESS TOBACCO PRODUCTS

 #46
20230338324
2023-10-26

Method for treating rheumatoid arthritis

 #47
20230321027
2023-10-12

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

 #48
20230310330
2023-10-05

PEPTIDIC OLIGOMERS AND METHODS OF USING THE SAME

 #49
20230301938
2023-09-28

TREATMENT OF COVID-19 ASSOCIATED COGNITIVE DYSFUNCTION BY NUTRACEUTICAL PREPARATIONS

 #50
20230293542
2023-09-21

SENSORY STIMULATING PSYCHOTROPIC DRUG

 #51
20230285500
2023-09-14

Compositions and Methods for Gene Therapy for Corneal Endothelium Disorders

 #52
20230285308
2023-09-14

Capsule to support the body's defense against microplastics

 #53
20230270711
2023-08-31

Improved Anti-Hangover Composition, Its Preparation and Uses

 #54
20230263763
2023-08-24

Method for treating infectious diseases with isothiocyanate functional compounds

 #55
20230255923
2023-08-17

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #56
20230255920
2023-08-17

Method for treating metastatic prostate cancer

 #57
20230241076
2023-08-03

HISTONE-ACETYLATION-MODULATING AGENTS FOR THE TREATMENT AND PREVENTION OF ORGAN INJURY

 #58
20230233594
2023-07-27

Compositions and Methods for Suppressing MSUT2

 #59
20230233505
2023-07-27

Method for Treating Psoriasis

 #60
20230226006
2023-07-20

Compositions for the Treatment of Dry Eye and Methods of Use Thereof

 #61
20230190720
2023-06-22

Pharmaceutical compositions comprising glitazones and Nrf2 activators

 #62
20230181670
2023-06-15

COMPOSITIONS AND METHODS FOR TREATMENT OF ALCOHOL INDUCED LIVER INJURY

 #63
20230165827
2023-06-01

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #64
20230150932
2023-05-18

COMPOSITIONS FOR STABILIZING AN ISOTHIOCYANATE

 #65
20230149499
2023-05-18

Curcumin compositions and methods of use as an NK3 antagonist

 #66
20230149488
2023-05-18

Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity

 #67
20230149420
2023-05-18

ANTI-INFLAMMATORY IMMUNOENHANCER

 #68
20230149417
2023-05-18

Prophylactic or therapeutic agent for hypoxic injury, ischaemia-reperfusion injury and inflammation, cell protection agent for transplantation, and bio-preservation agent

 #69
20230149412
2023-05-18

Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity

 #70
20230139025
2023-05-04

ANTIOXIDANT FOR USE IN TREATMENT FOR RIBE

 #71
20230127290
2023-04-27

MUSCLE REGENERATION

 #72
20230110036
2023-04-13

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

 #73
20230085607
2023-03-16

IVERMECTIN COMPOSITIONS FOR TREATMENT OF COVID-19

 #74
20230053524
2023-02-23

FUNGICIDES TO PREVENT AND CONTROL FUNGAL PATHOGENS

 #75
20230049330
2023-02-16

USE OF QX314 TO PREVENT SYMPATHOEXCITATION ASSOCIATED WITH ADMINISTRATION OF TRPV1 MODULATORS

 #76
20230023026
2023-01-26

METHODS FOR TREATMENT OF DAMAGED BILIARY DUCT

 #77
20220388954
2022-12-08

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

 #78
20220387535
2022-12-08

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MORINGA PLANT COMPONENTS

 #79
20220339228
2022-10-27

Antihypertensive Composition

 #80
20220257558
2022-08-18

Methods for restoring stem cell pools and reducing epigenetic age

 #81
20220193170
2022-06-23

Nutraceutical Reduction Prevention and/or Reversion of Multiple Sclerosis

 #82
20220193100
2022-06-23

COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF

 #83
20220160809
2022-05-26

Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin

 #84
20220160802
2022-05-26

METHODS AND COMPOSITIONS FOR PROMOTING HEALTH IN A SUBJECT

 #85
20220152116
2022-05-19

MULTI-STAGE PERSONALIZED LONGEVITY THERAPEUTICS

 #86
20220143123
2022-05-12

Prevention of Pathological Coagulation in COVID-19 and other Inflammatory Conditions

 #87
20220142963
2022-05-12

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #88
20220133784
2022-05-05

Medicine for Covid-19 and treatment

 #89
20220118062
2022-04-21

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER

 #90
20220079909
2022-03-17

Food Supplement For Improving Sports Performance

 #91
20220040248
2022-02-10

Prevention of neuroinflammation associated memory loss using nutraceutical compositions

 #92
20220031793
2022-02-03

Neuroprotection and neuroregeneration by pterostilbene and compositions thereof

 #93
20220000953
2022-01-06

Antihypertensive Composition

 #94
20210401791
2021-12-30

METHODS AND COMPOSITIONS FOR REDUCING ALCOHOL TOXICITY

 #95
20210369753
2021-12-02

NUTRIENT COMPOSITION ABLE TO INHIBIT QUORUM SENSING

 #96
20210346412
2021-11-11

Methods for reducing mitochondrial dysfunction

 #97
20210338763
2021-11-04

Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19

 #98
20210330629
2021-10-28

METHODS FOR TREATING MITOCHONDRIAL DISORDERS

 #99
20210315861
2021-10-14

Sulforaphane-melatonin-like compound

 #100
20210315855
2021-10-14

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #101
20210299230
2021-09-30

Medicine for Covid-19 and treatment

 #102
20210299199
2021-09-30

Neuron activator

 #103
20210259251
2021-08-26

Fungicides to prevent and control fungal pathogens

 #104
20210244703
2021-08-12

Use of scientifically matched plant supplements combined with antineoplastic compounds for the treatment of hematological malignancies

 #105
20210244702
2021-08-12

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

 #106
20210244701
2021-08-12

Method for treating infectious diseases with isothiocyanate functional compounds

 #107
20210236453
2021-08-05

Method for treating rheumatoid arthritis

 #108
20210228528
2021-07-29

Method for treating metastatic prostate cancer

 #109
20210220434
2021-07-22

Treatment of Vascular Occlusion by Activation of Notch Signaling

 #110
20210212978
2021-07-15

Method of synthesising sulforaphane

 #111
20210196694
2021-07-01

MUSCLE REGENERATION

 #112
20210187127
2021-06-24

CHALLENGE TEST FOR DIAGNOSING A SUBTYPE OF AUTISM SPECTRUM DISEASE

 #113
20210186922
2021-06-24

Compositions for promoting the endogenous self-renewal of stem cells

 #114
20210169997
2021-06-10

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

 #115
20210169782
2021-06-10

METHODS FOR TREATING EYE DISORDERS USING OCULAR IMPLANTS

 #116
20210161925
2021-06-03

Compositions for reducing mitochondrial dysfunction

 #117
20210128498
2021-05-06

Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide

 #118
20210106663
2021-04-15

TREATMENT OF MICROBIAL INFECTIONS

 #119
20210100751
2021-04-08

PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF

 #120
20210085746
2021-03-25

Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)

 #121
20210070730
2021-03-11

H2S-BASED THERAPEUTIC AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

 #122
20210069146
2021-03-11

Recognition ability improving agent

 #123
20210059972
2021-03-04

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #124
20210052580
2021-02-25

Combination Compositions and Therapies Comprising 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same

 #125
20210038610
2021-02-11

Prophylactic or therapeutic agent for hypoxic injury, ischemia-reperfusion injury and inflammation, cell protection agent for transplantation, and bio-preservation agent

 #126
20210030710
2021-02-04

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #127
20210030709
2021-02-04

Method for treating psoriasis

 #128
20210024463
2021-01-28

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

 #129
20210017130
2021-01-21

Use of isothiocyanate functional surfactants as NRF2 inducers to treat epidermolysis bullosa simplex and related diseases

 #130
20210009682
2021-01-14

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

 #131
20210008176
2021-01-14

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM

 #132
20210008024
2021-01-14

Regulation of cancer using natural compounds and/or diet

 #133
20200405680
2020-12-31

TRANSDERMAL FORMULATIONS

 #134
20200352215
2020-11-12

Use of isothiocyanate in smokeless tobacco products

 #135
20200339997
2020-10-29

Treatment for skeletal diseases caused by intracellular protein trafficking defects

 #136
20200289607
2020-09-17

COMPOSITIONS AND METHODS OF TREATMENT OF CORNEAL ENDOTHELIUM DISORDERS

 #137
20200289538
2020-09-17

Method for treating skin irritation caused by parabens

 #138
20200261553
2020-08-20

Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder

 #139
20200246301
2020-08-06

Compositions for the treatment of dry eye and methods of use thereof

 #140
20200230097
2020-07-23

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #141
20200206297
2020-07-02

COMPOSITIONS AND METHODS FOR TREATMENT OF ALCOHOL INDUCED LIVER INJURY

 #142
20200206239
2020-07-02

Inhibition of aminocylase 3 (AA3) in the treatment of cancer

 #143
20200206180
2020-07-02

Inhibitors of macrophage migration inhibitory factor

 #144
20200206179
2020-07-02

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

 #145
20200179324
2020-06-11

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #146
20200170989
2020-06-04

Method for treating skin cancer

 #147
20200101143
2020-04-02

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

 #148
20200101029
2020-04-02

METHOD AND SYSTEM FOR PRESERVING COGNITIVE CAPACITY DURING AGING

 #149
20200093780
2020-03-26

Compositions and Methods for Treating Autism Spectrum Disorders

 #150
20200069634
2020-03-05

Method for treating infectious diseases with isothiocyanate functional compounds

 #151
20200062702
2020-02-27

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

 #152
20200061016
2020-02-27

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

 #153
20200054061
2020-02-20

Methods and compositions for rapidly decreasing epigenetic age and restoration of more youthful function

 #154
20200046788
2020-02-13

COMPOSITIONS AND METHODS FOR TREATMENT OF INTESTINAL INFLAMMATION AND COLON CANCER

 #155
20200038360
2020-02-06

Inhibitors of macrophage migration inhibitory factor

 #156
20200030277
2020-01-30

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #157
20190388339
2019-12-26

Methods for treating eye disorders using ocular implants

 #158
20190381023
2019-12-19

Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators

 #159
20190380993
2019-12-19

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #160
20190374503
2019-12-12

Multivitamin capable of beneficial gene regulation through microRNA (MIRNA)

 #161
20190365696
2019-12-05

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

 #162
20190343784
2019-11-14

Methods for using stabilized sulforaphene

 #163
20190343161
2019-11-14

Method for treating chronic fatigue syndrome, idiopathic chronic fatigue, and fibromyalgia

 #164
20190330145
2019-10-31

Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases

 #165
20190328766
2019-10-31

Compositions and methods for suppressing MSUT2

 #166
20190292145
2019-09-26

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

 #167
20190284133
2019-09-19

Isothiocyanate functional surfactant and associated method of use

 #168
20190282534
2019-09-19

Method of synthesising sulforaphane

 #169
20190275119
2019-09-12

PROOXIDANT CANCER CHEMO-SUPPRESSORS AND CHEMO-PROTECTORS AND METHODS OF USE RELATED THERETO

 #170
20190240297
2019-08-08

TREATMENT OF INFLAMMATORY BOWEL DISEASE

 #171
20190225684
2019-07-25

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

 #172
20190183841
2019-06-20

Nutritional supplement and process of preparation

 #173
20190142781
2019-05-16

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #174
20190142780
2019-05-16

Use of isothiocyanate compounds

 #175
20190134230
2019-05-09

Challenge test for diagnosing subtypes of ASD

 #176
20190134229
2019-05-09

Method of identifying ASD phenotype 1 patients

 #177
20190134152
2019-05-09

Treatment of a subtype of ASD

 #178
20190134014
2019-05-09

Muscle regeneration

 #179
20190112263
2019-04-18

Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases

 #180
20190111018
2019-04-18

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #181
20190099462
2019-04-04

Neuron activator

 #182
20190046530
2019-02-14

PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS

 #183
20190030078
2019-01-31

Method of treating senescence with multi-stage longevity therapeutics

 #184
20190000791
2019-01-03

Isothiocyanatostilbenes as a novel method and product for treating cancer

 #185
20180353427
2018-12-13

Two-layer ocular implant

 #186
20180344680
2018-12-06

COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF DIABETES-RELATED SKIN ULCERS

 #187
20180338947
2018-11-29

COMPOSITIONS FOR ANTI-INFLAMMATORY, ANTIOXIDANT EFFECTS AND IMPROVED RESPIRATORY FUNCTION BY SPECIFIC HISTONE DEACETYLASE INHIBITION

 #188
20180311202
2018-11-01

Method for treating infectious diseases with isothiocyanate functional compounds

 #189
20180303786
2018-10-25

Inhibitors of macrophage migration inhibitory factor

 #190
20180303785
2018-10-25

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

 #191
20180290972
2018-10-11

Isothiocyanate functional surfactant and associated method of use

 #192
20180289661
2018-10-11

Method for treating skin cancer

 #193
20180289660
2018-10-11

Inhibitor of muscle damage or muscle fatigue

 #194
20180280339
2018-10-04

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #195
20180256532
2018-09-13

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

 #196
20180200344
2018-07-19

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER

 #197
20180200295
2018-07-19

In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system

 #198
20180162811
2018-06-14

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

 #199
20180133211
2018-05-17

METHODS AND MATERIALS FOR PROMOTING BONE FORMATION

 #200
20180133194
2018-05-17

METHOD OF TREATING INFLAMMATION USING NATURAL COMPOUNDS AND/OR DIET

 #201
20180104293
2018-04-19

Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain

 #202
20180098958
2018-04-12

Method for treating bladder cancer

 #203
20180042885
2018-02-15

Method for treating autism and other neurodevelopmental disorders

 #204
20180037545
2018-02-08

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

 #205
20180036279
2018-02-08

Multivitamin capable of beneficial gene regulation through microRNA (miRNA)

 #206
20180029979
2018-02-01

Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof

 #207
20180016229
2018-01-18

USE OF ISOTHIOCYANATE FUNCTIONAL SURFACTANTS AS NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES

 #208
20180008569
2018-01-11

PROSTAGLANDIN TRANSPORTER INHIBITORS FOR INHIBITING OVULATION

 #209
20170340595
2017-11-30

Compositions and methods for treating autism spectrum disorders

 #210
20170312243
2017-11-02

Short acting phenylalkylamine calcium channel blockers and uses thereof

 #211
20170312242
2017-11-02

Short acting phenylalkylamine calcium channel blockers and uses thereof

 #212
20170312241
2017-11-02

Short acting phenylalkylamine calcium channel blockers and uses thereof

 #213
20170290794
2017-10-12

Method for treating eczema

 #214
20170285034
2017-10-05

Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation

 #215
20170258822
2017-09-14

Anti-obesity composition

 #216
20170246138
2017-08-31

METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE

 #217
20170239207
2017-08-24

Method for treating skin cancer

 #218
20170181996
2017-06-29

Method for treating neurodegenerative diseases

 #219
20170152222
2017-06-01

Compounds and methods for inhibiting production of trimethylamine

 #220
20170151250
2017-06-01

Methods for inhibiting conversion of carnitine to trimethylamine (TMA)

 #221
20170151208
2017-06-01

Methods for inhibiting conversion of choline to trimethylamine (TMA)

 #222
20170143659
2017-05-25

Method for treating bladder cancer

 #223
20170112797
2017-04-27

Method for treating psoriasis

 #224
20170112796
2017-04-27

Method of synthesising sulforaphane

 #225
20170081281
2017-03-23

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

 #226
20170079936
2017-03-23

Compositions and methods relating to proliferative diseases

 #227
20170065607
2017-03-09

Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds

 #228
20170065571
2017-03-09

Pharmaceutical compositions comprising glitazones and NRF2 activators

 #229
20170065549
2017-03-09

COMPOSITIONS FOR ANTI-INFLAMMATORY, ANTIOXIDANT EFFECTS AND IMPROVED RESPIRATORY FUNCTION BY SPECIFIC HISTONE DEACETYLASE INHIBITION

 #230
20170065548
2017-03-09

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

 #231
20170037001
2017-02-09

Isothiocyanate functional surfactant formulation and associated method of use

 #232
20170037000
2017-02-09

Isothiocyanate functional surfactant and associated method of use

 #233
20160374982
2016-12-29

Short acting phenylalkylamine calcium channel blockers and uses thereof

 #234
20160374944
2016-12-29

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CANCER BY TARGETING AND INHIBITING CANCER STEM CELLS

 #235
20160354448
2016-12-08

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

 #236
20160287548
2016-10-06

MELANOMA CHEMOPREVENTION

 #237
20160287547
2016-10-06

Pharmaceutical composition for preventing or treating pulmonary fibrosis

 #238
20160279094
2016-09-29

Dietary and natural product management of negative side effects of cancer treatment

 #239
20160279090
2016-09-29

Process of preparation of nutritional supplement containing sulforaphane

 #240
20160250175
2016-09-01

Combined application of isothiocyanate compound and anti-cancer medicine

 #241
20160243057
2016-08-25

Methods of stabilizing the extracellular matrix and compositions therefor

 #242
20160220598
2016-08-04

Methods of treating and preventing diseases and disorders of the central nervous system

 #243
20160220526
2016-08-04

Method of treating or preventing tumors using 1-(alkylsulfinyl)-2-isothiocyanatoalkyl-1-alkene

 #244
20160106701
2016-04-21

Method for preventing and/or treating hairy wart disease

 #245
20160081920
2016-03-24

Method for forming a molded two-layer ocular implant

 #246
20160074354
2016-03-17

Short acting phenylalkylamine calcium channel blockers and uses thereof

 #247
20160067237
2016-03-10

Sensory Stimulation for Cessation of Eating

 #248
20160038485
2016-02-11

PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS

 #249
20160038456
2016-02-11

REGULATION OF CANCER USING NATURAL COMPOUNDS AND/OR DIET

 #250
20160030381
2016-02-04

Isothiocyanate functional surfactant and associated method of use

 #251
20160030380
2016-02-04

Isothiocyanate functional surfactant and associated method of use

 #252
20160030379
2016-02-04

Lysine derivative having an isothiocyanate functional group and associated method of use

 #253
20160022624
2016-01-28

Method for treating eczema

 #254
20160018399
2016-01-21

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS HAVING LUNG ADENOCARCINOMA CHARACTERIZED BY NEUROENDOCRINE DIFFERENTIATION

 #255
20160015677
2016-01-21

Method for treating eczema

 #256
20160015676
2016-01-21

Method for treating eczema

 #257
20160015675
2016-01-21

Method for treating skin cancer

 #258
20160015674
2016-01-21

Method for treating skin cancer

 #259
20160008313
2016-01-14

Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition

 #260
20150376124
2015-12-31

ANTI-CANCER COMPOSITIONS AND METHODS

 #261
20150362491
2015-12-17

METHODS AND ASSAYS RELATING TO RNF216

 #262
20150335663
2015-11-26

Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction

 #263
20150290164
2015-10-15

Sulforaphane for treating or reducing insulin resistance of the liver

 #264
20150238448
2015-08-27

FORMULATION OF RADIOPROTECTIVE ALPHA, BETA UNSATURATED ARYL SULFONES

 #265
20150196525
2015-07-16

Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder

 #266
20150191551
2015-07-09

Method of synthesising sulforaphane

 #267
20150191439
2015-07-09

Inhibitors targeting drug-resistant influenza A

 #268
20150174213
2015-06-25

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND URSOLIC ACID

 #269
20150174093
2015-06-25

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM

 #270
20150147352
2015-05-28

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

 #271
20150141507
2015-05-21

Melanoma chemoprevention

 #272
20150133507
2015-05-14

Pharmaceutical compositions comprising glitazones and Nrf2 activators

 #273
20150126600
2015-05-07

Isothiocyanate functional compound and associated method of use

 #274
20150118304
2015-04-30

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM

 #275
20150110872
2015-04-23

Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder

 #276
20150110863
2015-04-23

Sulforaphane-derived compounds, production method thereof and the medical, food and cosmetic use of same

 #277
20150087702
2015-03-26

METHODS AND COMPOSITIONS FOR REDUCING ALCOHOL TOXICITY

 #278
20150065431
2015-03-05

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

 #279
20150038580
2015-02-05

Method for treating skin cancer

 #280
20150038579
2015-02-05

Method for treating eczema

 #281
20150025049
2015-01-22

Compositions comprising exemestane and novel methods of use

 #282
20150023922
2015-01-22

Methods for promoting neuronal development and/or health

 #283
20150011626
2015-01-08

Methods of treating and preventing diseases and disorders of the central nervous system

 #284
20140322304
2014-10-30

Compositions and methods relating to proliferative diseases

 #285
20140314698
2014-10-23

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

 #286
20140256816
2014-09-11

Adamantyl derivatives as therapeutic agents

 #287
20140243267
2014-08-28

Use of NRF2 inducers to treat epidermolysis bullosa simplex and related diseases

 #288
20140228332
2014-08-14

Method for enhancing the secretion of GLP-1 using bitter compounds

 #289
20140134213
2014-05-15

Treatment of microbial infections

 #290
20140080795
2014-03-20

NRF2 Deficiency Influences Susceptibility to Steroid Resistance via HDAC2 Reduction

 #291
20130295203
2013-11-07

METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS

 #292
20130288985
2013-10-31

COMPOSITIONS AND METHODS OF TREATMENT OF CORNEAL ENDOTHELIUM DISORDERS

 #293
20130231387
2013-09-05

Prevention of proteomic and genomic damage by dicarbonyl substrates of Glo 1

 #294
20130165595
2013-06-27

Selenium-based biocidal formulations and methods of use thereof

 #295
20130165370
2013-06-27

Methods of treating steroid-induced obesity using GLP-1 agonists

 #296
20130164365
2013-06-27

Formulations for treatment with glucosinolates

 #297
20130158111
2013-06-20

Compositions and Methods for Depleting Mutant p53

 #298
20130158077
2013-06-20

PHARMACEUTICAL COMPOSITIONS

 #299
20130157965
2013-06-20

Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes

 #300
20130150346
2013-06-13

Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome